Nearly 1 in 4 cancer drug prices unchanged: Data

New Delhi: The Centre’s decision to cap trade margins on 137 non-scheduled anti-cancer drugs has reduced the maximum retail prices (MRPs) of 484 of 643 listed medicine packs, but left nearly one in four packs unchanged, raising questions about how much relief the measure will bring to cancer…

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to Hindustan Times's own reporting rather than reproducing it — the excerpt above comes from Hindustan Times's own feed.